Biofrontera Inc. Common Stock
Symbol: BFRI (NASDAQ)
0.92
▼ (-4.45%) -0.043
Company Description:
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
Key Stats
- Today's Open: $0.9452
- Today's High: $0.985
- Today's Low: $0.923
- Today's Volume: 53.96K
- Yesterday Close: $0.966
- Yesterday High: $1.06
- Yesterday Low: $0.9216
- Yesterday Volume: 35.78K
- Last Min Volume: 315
- Last Min High: $0.923
- Last Min Low: $0.923
- Last Min VWAP: $0.923
Company Profile
- Name: Biofrontera Inc. Common Stock
- Website: https://www.biofrontera-us.com
- Listed Date: 2021-10-29
- Location: WOBURN, MA
- Market Status: Active
- CIK Number: 0001858685
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $9.43M
- Round Lot: 100
- Outstanding Shares: 10.14M
- Asset Type: CS
RECENT FILINGS FOR BFRI
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-13 | S-1/A | View |
| 2025-08-13 | 8-K | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-08-11 | SCHEDULE 13G/A | View |
| 2025-08-05 | DEF 14A | View |
| 2025-07-25 | PRE 14A | View |
| 2025-07-25 | SCHEDULE 13D/A | View |
| 2025-07-16 | S-1 | View |
| 2025-07-16 | 8-K/A | View |
| 2025-07-11 | D | View |
| 2025-07-09 | 3 | View |
| 2025-07-01 | 8-K | View |
| 2025-06-30 | 8-K | View |
| 2025-06-18 | 8-K | View |
| 2025-06-11 | 8-K | View |
| 2025-06-03 | 8-K | View |
| 2025-06-03 | DEFR14A | View |
| 2025-05-23 | 8-K | View |
| 2025-05-15 | 8-K | View |
Latest News on BFRI